Use of xenon as neuroprotectant in a neonatal subject
AssigneeProtexeon Limited
InventorsNicholas Peter Franks, Mervyn Maze
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of xenon in the preparation of a medicament for preventing and/or alleviating one or more anesthetic-induced neurological deficits in a neonatal subject. The present invention further relates to combinations of xenon and sevoflurane, and use thereof as preconditioning agents for administration prior to hypoxic-ischaemic injury.
Claims26
1-93. (canceled)
A method of treating, preventing, and/or alleviating anesthetic-induced neurological deficits in a neonatal subject, the method comprising administering a therapeutically effective amount of xenon to said subject.
A method of providing anesthesia, neuroprotection, and/or analgesia to a neonatal subject, said method comprising administering xenon in combination with another anesthesia, wherein the amount of xenon is sufficient to alleviate and/or prevent anesthesia-induced neuronal injury.
A method of protecting against hypoxic injury comprising:
- administering xenon in combination with an anesthetic.
A method of treating, alleviating, and/or preventing neuronal necrosis in a subject, said method comprising administering a therapeutically effective amount of xenon to the patient.
Dependencies are inferred from the claim text.